BVS News and Press, Bioventus Inc. From 05/22/23

2023-05-22 06:35:00 ET Use These 3 Tips to Find Undervalued Penny Stocks in 2023 Understanding the stock market can be a challenging endeavor, yet it offers vast potential for substantial gains, particularly when it comes to penny stocks. Penny stocks , which typically trade below $...

2023-05-19 10:04:48 ET Gainers: Lucy Scientific Discovery ( LSDI ) +51% . Bioventus ( BVS ) +44% . Mallinckrodt ( MNK ) +28% . 180 Life Sciences ( ATNF ) +28% . Stereotaxis ( STXS ) +25% . Losers: Enveric Biosciences ( ENVB ...

2023-05-16 22:53:01 ET Bioventus Inc. (BVS) Q1 2023 Earnings Conference Call May 16, 2023, 05:00 PM ET Company Participants Dave Crawford - VP, IR Tony Bihl - CEO Mark Singleton - SVP and CFO Conference Call Participants Alex Nowak - Craig-Hallum Capi...

2023-05-16 16:54:07 ET Bioventus press release ( NASDAQ: BVS ): Q1 Non-GAAP EPS of -$0.26 misses by $0.10 . Revenue of $119.06M (+1.5% Y/Y) beats by $2.48M . 2023 Outlook: As previously disclosed, the Company has not provided financial guidance for fiscal 2...

DURHAM, N.C., May 16, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for the three months ended April 1, 2023. Q1 Financial Summary: Net Sales of $11...

DURHAM, N.C., May 15, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will now report financial results for the first quarter of fiscal year 2023 after ...

2023-05-10 09:27:43 ET Bioventus ( NASDAQ: BVS ) is selling its Wound business, including skin substitutes TheraSkin and TheraGenesis, to LifeNet Health for $85M. The total cash consideration of $85M, include $35M at close, a $5M payment deferred 18 months, and $45M in po...

DURHAM, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has signed a definitive agreement to sell its Wound business, including the skin ...

DURHAM, N.C., May 03, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the first quarter of fiscal year 2023 before the...

2023-04-05 08:16:31 ET Bioventus ( NASDAQ: BVS ) has announced that Ken M. Reali has stepped down as CEO and as a member of the Board of Directors. The board has initiated a comprehensive search process to identify a permanent CEO. Until a successor is named,...